Show simple item record

dc.contributor.authorDuncan, PJ
dc.contributor.authorTabak, J
dc.contributor.authorRuth, P
dc.contributor.authorBertram, R
dc.contributor.authorShipston, MJ
dc.date.accessioned2018-02-22T08:40:54Z
dc.date.issued2016-08-01
dc.description.abstractCorticotroph cells from the anterior pituitary are an integral component of the hypothalamic-pituitary-adrenal (HPA) axis, which governs the neuroendocrine response to stress. Corticotrophs are electrically excitable and fire spontaneous single-spike action potentials and also display secretagogue-induced bursting behavior. The HPA axis function is dependent on effective negative feedback in which elevated plasma glucocorticoids result in inhibition at the level of both the pituitary and the hypothalamus. In this study, we have used an electrophysiological approach coupled with mathematical modeling to investigate the regulation of spontaneous and CRH/arginine vasopressin-induced activity of corticotrophs by glucocorticoids. We reveal that pretreatment of corticotrophs with 100 nM corticosterone (CORT; 90 and 150 min) reduces spontaneous activity and prevents a transition from spiking to bursting after CRH/arginine vasopressin stimulation. In addition, previous studies have identified a role for large-conductance calcium- and voltage-activated potassium (BK) channels in the generation of secretagogue-induced bursting in corticotrophs. Using the dynamic clamp technique, we demonstrated that CRH-induced bursting can be switched to spiking by subtracting a fast BK current, whereas the addition of a fast BK current can induce bursting in CORT-treated cells. In addition, recordings from BK knockout mice (BK(-/-)) revealed that CORT can also inhibit excitability through BK-independent mechanisms to control spike frequency. Thus, we have established that glucocorticoids can modulate multiple properties of corticotroph electrical excitability through both BK-dependent and BK-independent mechanisms.en_GB
dc.description.sponsorshipThis work was supported by Grant 082407 from the Wellcome Trust (to M.J.S. and P.R.), Grant J008893 from the Medical Research Council (to M.J.S.), and Grant DK43200 from the National Institutes of Health (to R.B.). P.J.D. was supported by a Medical Reseach Council PhD studentship in the College of Medicine and Veterinary Medicine, University of Edinburgh.en_GB
dc.identifier.citationVol. 157, pp. 3108 - 3121en_GB
dc.identifier.doi10.1210/en.2016-1115
dc.identifier.urihttp://hdl.handle.net/10871/31617
dc.language.isoenen_GB
dc.publisherOxford University Pressen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/27254001en_GB
dc.rightsThis article has been published under the terms of the Creative Commons Attribution License (CC-BY; https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is retained by the author(s).en_GB
dc.titleGlucocorticoids inhibit CRH/AVP-evoked bursting activity of male murine anterior pituitary corticotrophs.en_GB
dc.typeArticleen_GB
dc.date.available2018-02-22T08:40:54Z
dc.identifier.issn0013-7227
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the final version of the article. Available on open access from the publisher via the DOI in this record.en_GB
dc.identifier.journalEndocrinologyen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record